C reactive protein impairs adaptive immunity in immune cells of patients with melanoma

BACKGROUND: High C reactive protein (CRP) levels have been reported to be associated with a poor clinical outcome in a number of malignancies and with programmed cell death protein 1 immune checkpoint blockade in patients with advanced cancer. Little is known about the direct effects of CRP on adapt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Tatsuya, Ichikawa, Junya, Giuroiu, Iulia, Laino, Andressa S, Hao, Yuhan, Krogsgaard, Michelle, Vassallo, Melinda, Woods, David M, Stephen Hodi, F, Weber, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204799/
https://www.ncbi.nlm.nih.gov/pubmed/32303612
http://dx.doi.org/10.1136/jitc-2019-000234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204799/
https://www.ncbi.nlm.nih.gov/pubmed/32303612
http://dx.doi.org/10.1136/jitc-2019-000234

Ejemplares similares